飞鹤的63年： 一场关于"更适合"的长期探索。 飞鹤，走过63年。 这个"更适合中国宝宝体质"的品牌，在过去的漫长时间里，时常被审视、被剖析，试图找到"更合适"关键词背后的成功逻辑。 一句深入人心的心智金句背后，并不缺乏模仿者。但真正能够迈过飞鹤护城河的品牌几乎没有。 为什么是飞鹤？ 它用数十年时间，回答了一个看似简单、实则复杂的问题，什么才叫"更适合"？就在10月14日，飞鹤举办了"更适合中国宝宝体质"科研突破暨新品发布 会，现场重磅发布了飞鹤"新一代更适合"升级，并宣布即将推出多款"新一代更适合"的婴儿奶粉新品。 这不是一次营销口号的更新，而是站在自身视角对于过往积累的一次系统性复盘。背后的逻辑是清晰的：科研能不能持续、产业能不能自控、实证能不能 量化，决定了"适合"的深度和厚度。 而这，正是飞鹤想要证明的。 63年，成就"新一代更适合" 63年，对于一个乳企来说，不只是时间的长度，更是行业坐标的纵深。 今天的年轻父母，很多人小时候喝过飞鹤；而他们的孩子，正在成为"新一代更适合"的受益者。 从北大荒走出的那一代飞鹤人开始，品牌就把奶粉视为"母亲的事业、良心的事业"。2001年，它确立"更适合"的核心命题； ...

Core Insights - The article discusses the unique competitive advantage of Feihe, a brand that has established itself as "more suitable for Chinese babies' physique" over its 63 years of existence, emphasizing its deep-rooted research and development efforts [1][3][19] - Feihe's approach to creating infant formula is based on a comprehensive understanding of Chinese maternal and infant needs, which sets it apart from international brands that often rely on standardized global practices [7][20] Group 1: Brand Development and Strategy - Feihe has built its brand on the premise of being "more suitable," which is supported by decades of research and a self-controlled supply chain that spans from pasture to production [6][9] - The company has established a unique "two-hour ecological circle" that ensures fresh milk is processed within two hours, significantly enhancing the nutritional quality of its products [11][21] - Feihe's commitment to research is evident in its participation in national projects and the establishment of a large maternal and infant database, which informs its product development [15][16] Group 2: Research and Innovation - The brand has developed a proprietary understanding of the nutritional needs of Chinese infants, leading to innovations in formula composition that align closely with the nutritional profile of Chinese breast milk [10][14] - Feihe's research efforts have resulted in significant scientific contributions, including over 200 published papers and nearly 700 patents, positioning it as a leader in the field of infant nutrition [15][16] - The company has created a robust clinical validation system that continuously tests and refines its products based on real-world data, enhancing consumer trust [12][21] Group 3: Market Position and Competitive Advantage - Feihe's strategy has allowed it to redefine industry standards, moving the focus from cost and scale to quality and scientific validation, thereby establishing a new competitive landscape in the dairy industry [20][21] - The brand's ability to integrate research with market needs has resulted in sustained sales leadership in China and globally, demonstrating the effectiveness of its research-driven approach [17][18] - Feihe's comprehensive system of research, production, and validation creates a formidable barrier to entry for competitors, making its model difficult to replicate [19][21]

Core Viewpoint - The article emphasizes the importance of tailored nutrition for Chinese babies, highlighting the advancements made by Feihe in producing milk powder that aligns with local dietary needs and scientific research [3][11][19]. Group 1: Product Differentiation - Feihe's marketing slogan "more suitable for Chinese babies" has gained significant attention, leading to a broader discussion about product suitability in various contexts [3]. - The company has launched new products that focus on measurable scientific standards to evaluate the suitability of milk powder for Chinese infants [11][19]. Group 2: Milk Source and Freshness - Feihe has established 13 self-owned farms and 115,000 dairy cows to ensure high-quality, controllable milk sources, addressing past concerns about domestic milk quality [11][12]. - The company emphasizes a closed cold chain process, reducing the time from milking to processing to under two hours, which enhances the nutritional value of the milk [12][13]. - Feihe's milk quality exceeds EU standards significantly, with protein content ≥3.4% and bacterial count ≤0.5 million, showcasing its commitment to high-quality production [12][13]. Group 3: Research and Development - Feihe has invested in extensive research, including over 40 national and provincial projects, to develop a comprehensive understanding of breast milk composition and its implications for infant nutrition [16][17]. - The company has published 207 papers and holds 698 patents, demonstrating its commitment to advancing nutritional science [17]. Group 4: Formula Design - The formula design is based on a deep understanding of the nutritional components of Chinese breast milk, ensuring that the milk powder is tailored to local dietary habits and genetic factors [16][17]. - Feihe's recent product upgrades include innovations like HMOs, probiotics, and a proprietary Brain Matrix, which closely mimic the nutritional profile of breast milk [17][19]. Group 5: Evidence-Based Results - Feihe conducts clinical trials to validate the effectiveness of its products, ensuring that claims about nutritional benefits are backed by scientific evidence [19][21]. - The company has successfully demonstrated the impact of its formulations on various aspects of infant development, including growth, digestion, and immune function [21]. Group 6: Market Positioning - Feihe's approach to building trust through transparency and scientific validation has led to a strong market presence, with over 100 million mothers choosing its products [21][23]. - The article concludes that Feihe's commitment to quality and research positions it as a leader in the domestic milk powder market, setting a standard for others to follow [23].

Core Insights - The "Northeast Really Works" microfilm series produced by Feihe has gained significant attention, achieving an online exposure of 848 million by October 9, showcasing the company's commitment to its roots and the "more suitable" promise for Chinese babies [1][3]. Group 1: Company Commitment and Initiatives - Feihe emphasizes its responsibility in revitalizing the Northeast by creating "more suitable offers for Northeast children," reflecting its dedication to local development and community support [3][8]. - The company has created 170,000 jobs and helped over 160,000 farmers increase their income, contributing to the appreciation of over one million acres of farmland in Heilongjiang [8]. - Feihe has invested 1.2 billion in a fertility subsidy program and has donated 650 million to support education in Heilongjiang, demonstrating its commitment to corporate social responsibility [8]. Group 2: Technological and Operational Advancements - Feihe has established the first modern dairy farm in China and the first large-scale automated production line for lactoferrin, showcasing its commitment to technological innovation and domestic production [4]. - The company has integrated AI systems for real-time monitoring of milk powder production, achieving full digital operation across its processes [4][12]. - Feihe's proprietary milk sources have a bacterial index that is 20 times better than EU standards, ensuring high product quality from the source [10]. Group 3: Product Development and Research - Feihe leads national key research projects and has established the largest maternal and infant health cohort in China, pushing the boundaries of infant formula research [12]. - The company has developed innovative formulas with a DHA to ARA ratio of 1:1.7 and significantly enhanced nutrient absorption rates, making its products more suitable for Chinese infants [12][14]. - Feihe has maintained its position as the top seller in the Chinese infant formula market for six consecutive years and ranks first globally, with a brand recognition rate of 99% as of Q2 2025 [15].